Empiriko Corp is a cutting-edge technology company based in Newton Lower Falls, MA, specializing in interconnected platforms that revolutionize drug research and development. Their Biomimiks platform accelerates the creation of safer and more effective drugs, while their Personalized Metabolic Fingerprint device provides personalized diagnostics at the point-of-care, improving outcomes for individuals and populations.
By seamlessly connecting the data flow between these two platforms, Empiriko Corp creates a range of opportunities to accelerate drug development, enhance clinical outcomes, and bring the power of precision medicine to the forefront. Their innovative approach eliminates the need for animal testing and enables early disease detection and therapeutic monitoring through the assessment of chemical drug, immunologic, and genetic biomarkers.
Generated from the website